close
    why is elan share price rising

    0  Views: 724 Answers: 1 Posted: 10 years ago

    1 Answer

    a proprietary survey of multiple sclerosis specialists suggests the market position of Elan's MS drug Tysabri against Novartis AG's (NVS, NOVN.VX) Gilenya is secure.


    Top contributors in Uncategorized category

     
    ROMOS
    Answers: 18064 / Questions: 153
    Karma: 1101K
     
    Colleen
    Answers: 47272 / Questions: 115
    Karma: 953K
     
    country bumpkin
    Answers: 11324 / Questions: 160
    Karma: 838K
     
    Benthere
    Answers: 2393 / Questions: 30
    Karma: 759K
    > Top contributors chart

    Unanswered Questions

    447063
    questions
    717310
    answers
    692301
    users